Tables 2, 3 show that the high expression of SIRT5 is a good independent predictor of DSS and PFI, respectively, in glioma patients (p < 0.05), whereas, high expression of SIRT7 was an independent predictor of poor PFI in glioma patients (p < 0.05). This evidence concerns the gene SIRT5 and central nervous system cancer.